PERSPECTA

News from every angle

Back to headlines

Novo Nordisk Considers Bangladesh as Insulin Production Hub

Pharmaceutical company Novo Nordisk is exploring the possibility of establishing Bangladesh as a central hub for insulin production.

26 Jun, 00:05 — 26 Jun, 00:05
PostShare